Of these, MLL-AF9 (MA9) t(9;11)(p22;q23) translocations are found in 30% of MLLr AML cases [5] irrespective of age and are commonly found in a subset of adult patients with therapy-related AML [8]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.